These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10981338)
1. [Dose intensity of chemotherapy in small-cell lung carcinoma. Review of comparative studies]. Sanz Rubiales A; del Valle Rivero ML; Garavís Vicente M; Rey Castro P; López-Lara Martín F An Med Interna; 2000 Jul; 17(7):378-85. PubMed ID: 10981338 [TBL] [Abstract][Full Text] [Related]
2. [The place for therapeutic intensification in small cell lung cancer]. Corne F; Thiberville L Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S104-9. PubMed ID: 15536362 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy dose intensity facilitated by use of lenograstim--implications for quality of life and survival. Gisselbrecht C Eur J Cancer; 1994; 30A Suppl 3():S30-3. PubMed ID: 7535070 [TBL] [Abstract][Full Text] [Related]
4. Increasing chemotherapy in small-cell lung cancer: from dose intensity and density to megadoses. Crivellari G; Monfardini S; Stragliotto S; Marino D; Aversa SM Oncologist; 2007 Jan; 12(1):79-89. PubMed ID: 17227903 [TBL] [Abstract][Full Text] [Related]
5. Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer. Lorigan P; Woll PJ; O'Brien ME; Ashcroft LF; Sampson MR; Thatcher N J Natl Cancer Inst; 2005 May; 97(9):666-74. PubMed ID: 15870437 [TBL] [Abstract][Full Text] [Related]
6. The importance of chemotherapy dose intensity in lung cancer. Crawford J Semin Oncol; 2004 Dec; 31(6 Suppl 15):25-31. PubMed ID: 15726536 [TBL] [Abstract][Full Text] [Related]
7. Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop. Aisner J; Alberto P; Bitran J; Comis R; Daniels J; Hansen H; Ikegami H; Smyth J Cancer Treat Rep; 1983 Jan; 67(1):37-43. PubMed ID: 6311413 [TBL] [Abstract][Full Text] [Related]
8. [Dose intensity of chemotherapy in small-cell lung carcinoma]. Borg C; Ligneau B; Trillet-Lenoir V Bull Cancer; 2001 Sep; 88(9):863-70. PubMed ID: 11604359 [TBL] [Abstract][Full Text] [Related]
9. [Perspectives on chemotherapy of cancer of the bronchi]. Chauvergne J; Chomy P Rev Mal Respir; 1989; 6(5):409-16. PubMed ID: 2557652 [TBL] [Abstract][Full Text] [Related]
10. Relevance of high-dose chemotherapy in solid tumours. Nieboer P; de Vries EG; Mulder NH; van der Graaf WT Cancer Treat Rev; 2005 May; 31(3):210-25. PubMed ID: 15944050 [TBL] [Abstract][Full Text] [Related]
11. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial. Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G; J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095 [TBL] [Abstract][Full Text] [Related]
12. G-CSF for fever and neutropenia induced by chemotherapy. Hamm JT N Engl J Med; 1992 Jan; 326(4):269; author reply 270. PubMed ID: 1370180 [No Abstract] [Full Text] [Related]
13. Small cell lung cancer: strategies to optimize chemotherapy response. Psyrri A; Murren J Cancer J; 2001; 7 Suppl 1():S28-34. PubMed ID: 11504283 [TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy in small-cell lung cancer. Pasini F; Durante E; De Manzoni D; Rosti G; Pelosi G Anticancer Res; 2002; 22(6B):3465-72. PubMed ID: 12552940 [TBL] [Abstract][Full Text] [Related]
15. A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics. Sculier JP; Paesmans M; Lecomte J; Van Cutsem O; Lafitte JJ; Berghmans T; Koumakis G; Florin MC; Thiriaux J; Michel J; Giner V; Berchier MC; Mommen P; Ninane V; Klastersky J; Br J Cancer; 2001 Nov; 85(10):1444-51. PubMed ID: 11720426 [TBL] [Abstract][Full Text] [Related]
16. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer. Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659 [TBL] [Abstract][Full Text] [Related]
17. Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study. Le QT; McCoy J; Williamson S; Ryu J; Gaspar LE; Edelman MJ; Dakhil SR; Sides SD; Crowley JJ; Gandara DR; Clin Cancer Res; 2004 Aug; 10(16):5418-24. PubMed ID: 15328179 [TBL] [Abstract][Full Text] [Related]
18. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study. Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098 [TBL] [Abstract][Full Text] [Related]
19. Impact of neutropenia on delivering planned chemotherapy for solid tumours. Khan S; Dhadda A; Fyfe D; Sundar S Eur J Cancer Care (Engl); 2008 Jan; 17(1):19-25. PubMed ID: 18181887 [TBL] [Abstract][Full Text] [Related]
20. Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma. Tas F; Derin D; Guney N; Camlica H; Aydiner A; Topuz E Lung Cancer; 2007 Jul; 57(1):79-83. PubMed ID: 17383768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]